<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gumusoglu SB</submitter><funding>American Heart Association</funding><funding>NICHD NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>Carver College of Medicine and Iowa Neuroscience Institute Carver Trust Early-Stage Investigator award</funding><funding>University of Iowa Summer Undergraduate Research Fellowship</funding><funding>U.S. Department of Health &amp;amp; Human Services | National Institutes of Health</funding><funding>Iowa Medical Student Research Program Summer Fellowship</funding><pagination>864-875</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10948883</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>49(5)</volume><pubmed_abstract>Psychiatric and obstetric diseases are growing threats to public health and share high rates of co-morbidity. G protein-coupled receptor signaling (e.g., vasopressin, serotonin) may be a convergent psycho-obstetric risk mechanism. Regulator of G Protein Signaling 2 (RGS2) mutations increase risk for both the gestational disease preeclampsia and for depression. We previously found preeclampsia-like, anti-angiogenic obstetric phenotypes with reduced placental Rgs2 expression in mice. Here, we extend this to test whether conserved cerebrovascular and serotonergic mechanisms are also associated with risk for neurobiological phenotypes in the Rgs2 KO mouse. Rgs2 KO exhibited anxiety-, depression-, and hedonic-like behaviors. Cortical vascular density and vessel length decreased in Rgs2 KO; cort</pubmed_abstract><journal>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</journal><pubmed_title>Anti-angiogenic mechanisms and serotonergic dysfunction in the Rgs2 knockout model for the study of psycho-obstetric risk.</pubmed_title><pmcid>PMC10948883</pmcid><funding_grant_id>R01 HD089940</funding_grant_id><funding_grant_id>HD089940</funding_grant_id><funding_grant_id>18SCG34350001</funding_grant_id><funding_grant_id>P50HD10355601A1</funding_grant_id><funding_grant_id>19IPLOI34760288</funding_grant_id><funding_grant_id>T32 HL007344</funding_grant_id><funding_grant_id>22POST30908921</funding_grant_id><funding_grant_id>HD000849</funding_grant_id><funding_grant_id>5T32HL007121-45</funding_grant_id><funding_grant_id>3UL1TR002537</funding_grant_id><funding_grant_id>RR024980</funding_grant_id><pubmed_authors>Weaver KR</pubmed_authors><pubmed_authors>Coulter KJ</pubmed_authors><pubmed_authors>Kamal M</pubmed_authors><pubmed_authors>Sullivan HR</pubmed_authors><pubmed_authors>Gantz SC</pubmed_authors><pubmed_authors>Schickling BM</pubmed_authors><pubmed_authors>Blaine BM</pubmed_authors><pubmed_authors>Gumusoglu SB</pubmed_authors><pubmed_authors>Kiel MD</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Santillan DA</pubmed_authors><pubmed_authors>Lauffer MC</pubmed_authors><pubmed_authors>Devor EJ</pubmed_authors><pubmed_authors>Gugel A</pubmed_authors><pubmed_authors>Santillan MK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Anti-angiogenic mechanisms and serotonergic dysfunction in the Rgs2 knockout model for the study of psycho-obstetric risk.</name><description>Psychiatric and obstetric diseases are growing threats to public health and share high rates of co-morbidity. G protein-coupled receptor signaling (e.g., vasopressin, serotonin) may be a convergent psycho-obstetric risk mechanism. Regulator of G Protein Signaling 2 (RGS2) mutations increase risk for both the gestational disease preeclampsia and for depression. We previously found preeclampsia-like, anti-angiogenic obstetric phenotypes with reduced placental Rgs2 expression in mice. Here, we extend this to test whether conserved cerebrovascular and serotonergic mechanisms are also associated with risk for neurobiological phenotypes in the Rgs2 KO mouse. Rgs2 KO exhibited anxiety-, depression-, and hedonic-like behaviors. Cortical vascular density and vessel length decreased in Rgs2 KO; cort</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-06-01T10:13:13.871Z</modification><creation>2025-06-28T03:05:59.186Z</creation></dates><accession>S-EPMC10948883</accession><cross_references><pubmed>37848733</pubmed><doi>10.1038/s41386-023-01749-3</doi></cross_references></HashMap>